1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Drug Focus OCTOBER 2016

Autoimmune Drug Focus OCTOBER 2016

  • October 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Arthritis Set To Lead Field In New Autoimmune Drugs
Industry Brief - Neovacs Signs Deal To Achieve PoC For IFNalpha-Kinoid In Type I Diabetes
Industry Brief - Sotagliflozin Phase II Dose-Ranging Study Meets Primary Endpoint
Industry Brief - Filgotinib To Progress To Phase III Studies
Industry Trend Analysis - MEDI2070 Promises Potential Rewards In An Increasingly Competitive Marketplace
Industry Brief - Tillotts Secures Japanese Zentacort Approval
Industry Brief - TiGenix' Cx601 Granted Crohn's Disease ODD
Industry Brief - First Patients Dosed In TOP1288 Phase IIa PoC Study For UC
Industry Brief - Cellceutix Reports Interim Results From Brilacidin Phase II UP\UPS Trial
Industry Brief - Apitope Regains Global Rights To Novel MS Treatment
Industry Brief - RedHill Receives Japanese Patent NoA Supporting RHB-104 For MS
Industry Brief - Actemra Granted FDA Breakthrough Therapy Designation In GCA
Industry Trend Analysis - Celltrion Agreement Will Reinvigorate Teva's Biosimilar Efforts
Industry Brief - Cimzia AutoClicks Prefilled Pen Now Available On NHS
Industry Trend Analysis - Adalimumab Taking Shape As Next Major Biosimilar Competition Market
Industry Brief - Lumicef Launch In Japan For Psoriasis
Industry Brief - Cimzia Phase III Trial Meets Co-Primary Efficacy Endpoint
Industry Brief - Guselkumab Shows Superiority Over Humira In Phase III Plaque Psoriasis Study
Industry Brief - Late-Breaking Data Revealed For Cosentyx In Psoriasis At Four Years
Industry Brief - Biocad's BCD-085 Phase II Trial Initiated In Severe Psoriasis
Industry Brief - Otezla Gains NICE Chronic Plaque Psoriasis Recommendation
Industry Brief - Voclosporin Achieves Pre-Specified Secondary Endpoints In Phase IIb LN Study
Industry Brief - Evotec Enters Into Collaboration With C4X Discovery
Industry Brief - First Patient Treated With IdeS In Phase II Acquired TTP study
Industry Brief - TNT009 Gains ODD for Treatment Of Autoimmune Haemolytic Anaemia
Industry Brief - Selexis/ImmuNext Enter Deal For Anti-CD40L Antibody To Treat Chronic Autoimmune Disorders
Industry Trend Analysis - Shire Turns Away From Biosimilars
Industry Brief - Allergan's Acquisition Of Vitae Progresses
Industry Brief - True North Therapeutics Completes Fundraising
Industry Trend Analysis - South Africa Will Be The First Stage In Cipla's Wider Biosimilar Ambitions
Industry Brief - Autoimmune Conferences - January 2017

Table Of Contents

Autoimmune Drug Focus OCTOBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Scleroderma Diagnostics and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Scleroderma Diagnostics and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Scleroderma Diagnostics and Therapeutics Market: Overview Scleroderma, a very rare autoimmune disorder of the skin, is a term coined from the Greek words “sklerosis,” which means hardness, and ...

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The U.S. IVD for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach a value of USD 4.74 billion by 2024 .The U.S. Laboratory Developed Test (LDT) for autoimmune diseases ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.